Drug Trial Radar · NCT03562637
Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC
Last checked: Nov 19, 2026Latest source record: May 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
575
Actual
Start
Dec 5, 2018
Primary completion
Dec 30, 2025
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- OBI Pharma, IncIndustry
- Sponsor type
- Industry
- First posted
- Jun 19, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The GLORIA study is a Phase III, randomized, open-label study to prospectively evaluate the efficacy and safety of adagloxad simolenin (OBI 822)/OBI-821 in the adjuvant treatment of patients with high risk, early stage Globo-H Positive TNBC.
Conditions
- Triple Negative Breast Cancer
Interventions
adagloxad simolenin combined with OBI-821Biological
In the neoadjuvant and adjuvant phases of the study for a total of 100 weeks; subcutaneously injections.
Globo H IHC AssayDevice
The Globo H IHC assay will be used to identify eligible patients who may clinically benefit from the OBI-822 treatment, defined by Globo H expression.
Standard of care treatmentOther
Standard of care treatment consisting of observation alone, adjuvant capecitabine or platinum monotherapy over a 100 week period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Measuring the effect of adagloxad simolenin (OBI-822)/OBI-821 treatment on improving invasive disease free survival (IDFS) in the study population.Time frame: 5 years
Locations
128 sites in 13 countries. Site status is shown where the registry gives one.
Moores UCSD Cancer Center
La Jolla, California
Kaiser Permanente Medical Center
San Diego, California
UCSF Helen Diller Family Comprehensive Cancer Centre
San Francisco, California
Miami Cancer Institute
Miami, Florida
University of Chicago Medical
Chicago, Illinois
University of Maryland Greenbaum Comprehensive Cancer Center
Baltimore, Maryland
Henry Ford Medical Center
Detroit, Michigan
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey
Magee-Womens Hospital of UPMC
Pittsburgh, Pennsylvania
University of Texas Health Science Center at San Antonio
San Antonio, Texas
Bons Secours St. Francis Medical Oncology Center
Midlothian, Virginia
Northwest Medical Specialties, PLLC
Tacoma, Washington
St Vincent's Hospital Sydney
Darlinghurst, Australia
Gosford Hospital
Gosford, Australia
St John of God Murdoch Hospital
Murdoch, Australia
Eastern Health - Maroondah Hospital
Ringwood East, Australia
Westmead Hospital
Westmead, New South Wales, Australia
Cancer Care Service, Hervey Bay Hospital
Urraween, Queensland, Australia
Victoria Breast & Oncology Care
East Melbourne, Victoria, Australia
Cabrini Malvern
Malvern, Victoria, Australia
Breast Cancer Research Centre
Nedlands, Western Australia, Australia
Suporte Nutricional e Quimioterapia
Fortaleza, Ceará, Brazil
Centro de Avaliacao de Medicamentos e Especialidades de Pesquisa
Serra, Espírito Santo, Brazil
Hospital Sao Rafael
Salvador, Estado de Bahia, Brazil
Instituto Mario Penna
Belo Horizonte, Minas Gerais, Brazil
Centro de Tratamento Oncologico LTDA - CTO
Belém, Pará, Brazil
Maternidade e Cirurgia Nossa Senhora do Rocio
Campo Largo, Paraná, Brazil
Hospital das Clinicas - Universidade Federal do Parana
Curitiba, Paraná, Brazil
Hospital do Capibaribe
Recife, Pernambuco, Brazil
Real Hospital Portugues de Beneficencia de Pernambuco
Recife, Pernambuco, Brazil
Centro de Pesquisa Vencer & Oncolinca
Teresina, Piauí, Brazil
Hospital de Clinicas de Porto Alegre
Barretos, Rio Grande do Sul, Brazil
Oncosite-Centro de Pesquisa Clinica em Oncologia
Ijuí, Rio Grande do Sul, Brazil
Hospital Escola da Universidade Federal de Pelotas
Pelotas, Rio Grande do Sul, Brazil
Irmandade da Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS) - Hospital Sao Lucas
Porto Alegre, Rio Grande do Sul, Brazil
Hospital de Amor Amazonia
Porto Velho, Rondona, Brazil
Centro Oncologico de Roraima
Boa Vista, Roraima, Brazil
Clinica Supera
Chapecó, Santa Catarina, Brazil
Clinica de Neoplasias Litoral - Itajai
Itajaí, Santa Catarina, Brazil
Showing 40 of 128 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.